Allison Way
Senior Vice President, Investor Relations and Corporate Communications
Replay available
Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) Q2 2025 earnings conference call, held 2025-08-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
John Shannon
CEO
Steve Piper
CFO
Chase Nickerbocker
Analyst, Craig & Hallam
Chris Clark
Analyst, Leerink Partners
Jason Dore
Analyst, Oppenheimer & Co.
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Xeris Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.000 -- 00:00:05.420 and thank you for joining the Zarius RFRMA second quarter 2025 earnings conference call. 00:00:05.420 -- 00:00:08.500 My name is Sammy, and I'll be coordinating your call today. 00:00:08.500 -- 00:00:12.180 During the presentation, you can register a question by pressing star followed by one 00:00:12.180 -- 00:00:15.900 on your telephone keypad. If you change your mind, please press star followed by two 00:00:15.900 -- 00:00:19.620 on your telephone keypad to remove yourself from the question queue. 00:00:19.620 -- 00:00:23.740 I'll now hand over to your host, Allison Way, Senior Vice President of Investor Relations 00:00:23.740 -- 00:00:28.120 and Corporate Communications to begin. Please go ahead, Allison. 00:00:28.120 -- 00:00:32.760 Thank you, Sammy. Good morning, everyone, and thank you for joining our call today. 00:00:32.760 -- 00:00:37.320 I'm joined with John Shannon, our CEO, and Steve Piper, our CFO. 00:00:37.320 -- 00:00:40.860 Earlier this morning, we issued a press release with our detailed results, which can 00:00:40.860 -- 00:00:46.100 be found on our website. After our prepared remarks, we will open the lines for questions. 00:00:46.100 -- 00:00:51.040 Before we would begin, I'd like to remind you that this call will contain forward-looking 00:00:51.040 -- 00:00:55.400 statements concerning the company's future expectations, plans, projects, and financial 00:00:55.400 -- 00:01:00.160 performance. Forward-looking statements are subject to risks and uncertainties that could 00:01:00.160 -- 00:01:04.720 cause actual results to differ materially from those forward-looking statements. 00:01:04.720 -- 00:01:08.760 For more information on a risk, please refer to our earnings release and the risk factors 00:01:08.760 -- 00...